<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Inbox Robot: Cephalon News</title>
<link>http://www.inboxrobot.com/news/cephalon</link><description>Constantly updated news and information about a variety of topics.</description><item>
<title>Pharmacopeia to Present At the BMO Capital Markets 8th Annual Focus On Healthcare Conference</title>
<link>http://www.inboxrobot.com/news.php?fid=179850204</link>
<pubDate>23 Jul 2008 11:51 GMT</pubDate>
<description>
...  has established strategic alliances with major pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Schering-Plough, and Wyeth Pharmaceuticals. For more information please visit the company&apos;s website at  ...
</description>
</item><item>
<title>US CONGRESSIONAL INVESTIGATION INTO RANBAXY - Patent Avoidance, Generics and the Hatch-Waxman maze</title>
<link>http://www.inboxrobot.com/news.php?fid=179423317</link>
<pubDate>20 Jul 2008 21:30 GMT</pubDate>
<description>
...  generics through the Hatch-Waxman route. As recently as February 16, 2008, the FTC sued Cephalon &quot;for a course of anticompetitive conduct that is preventing competition to its branded drug  ...
</description>
</item></channel>
</rss>
